Lundbeck CEO, Deborah Dunsire, is retiring. Charl van Zyl, Head of Neurology at UCB, has been hired to replace her no later than October 1st. Dunshire has been with Lundbeck for nearly 5 years and is leaving on a high note as they hit a record-high quarterly revenue after a 19% growth during the first three months of 2023.
Click here to read the entire article.